doi: 10.1016/j.mayocpiqo.2019.03.002
In this article we provide an overview of the pathophysiology and management of NASH, with a special focus on the pharmacological effects and possible mechanisms of GLP-1 mimetics in treating NAFLD/NASH, including dual and triple agonists at GLP-1R, glucose-dependent insulinotropic polypeptide receptor or glucagon receptor
After 12 h incubation, cells were treated with PBS, Ru(II)-OH, NP2, or NP4 for 24 h (Ru 10 M), washed with PBS and incubated with Annexin/PI reagent in the dark for 15 min at 25 C
Around my kids Im a marshmallow and, he jokes, the mommy is the psychopath. Grillos career burst is productive but hardly glamorous
Furthermore, differences in the bioavailability of different sulforaphane preparations can limit efficacy
Astrocyte activation in neurovascular damage and repair following ischaemic stroke